About the Startup
French biotech developing first-in-class small molecules that inhibit necroptosis and ferroptosis to protect organs; lead candidates SBL03 for dry AMD and SBL01 for severe acute hepatitis.
Source: https://tech.eu/2025/10/01/french-biotech-seabelife-raises-2m-to-treat-liver-and-eye-diseases/
Frequently Asked Questions
What type of funding round did SeaBeLife raise?
SeaBeLife raised a bridge round.
How much did SeaBeLife raise in its bridge?
SeaBeLife raised $2,000,000 USD in its bridge.
Who invested in SeaBeLife's bridge?
The investors in SeaBeLife's bridge are: iXLife, INEXT, Breizh Angels, WeLikeStartup, Angels Santé, Business Angels des Grandes Ecoles, Femmes Business Angels.
What type of investment was SeaBeLife's bridge?
SeaBeLife's bridge was a equity investment.